Product Code: ETC10144383 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Zimbabwe Neuraminidase Inhibitors Market Overview |
3.1 Zimbabwe Country Macro Economic Indicators |
3.2 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 Zimbabwe Neuraminidase Inhibitors Market - Industry Life Cycle |
3.4 Zimbabwe Neuraminidase Inhibitors Market - Porter's Five Forces |
3.5 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Zimbabwe Neuraminidase Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in awareness about the importance of neuraminidase inhibitors in treating influenza |
4.2.2 Rising prevalence of influenza cases in Zimbabwe |
4.2.3 Technological advancements leading to the development of more effective neuraminidase inhibitors |
4.3 Market Restraints |
4.3.1 High cost associated with neuraminidase inhibitors |
4.3.2 Limited access to healthcare services in certain regions of Zimbabwe |
4.3.3 Potential side effects and safety concerns related to neuraminidase inhibitors |
5 Zimbabwe Neuraminidase Inhibitors Market Trends |
6 Zimbabwe Neuraminidase Inhibitors Market, By Types |
6.1 Zimbabwe Neuraminidase Inhibitors Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type A, 2021- 2031F |
6.1.4 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type B, 2021- 2031F |
6.1.5 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Zimbabwe Neuraminidase Inhibitors Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Zanamivir, 2021- 2031F |
6.2.3 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Oseltamivir, 2021- 2031F |
6.2.4 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Peramivir, 2021- 2031F |
6.2.5 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Laninamivir, 2021- 2031F |
6.2.6 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Zimbabwe Neuraminidase Inhibitors Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Inhalation, 2021- 2031F |
6.3.4 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.5 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Zimbabwe Neuraminidase Inhibitors Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Zimbabwe Neuraminidase Inhibitors Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Zimbabwe Neuraminidase Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Zimbabwe Neuraminidase Inhibitors Market Import-Export Trade Statistics |
7.1 Zimbabwe Neuraminidase Inhibitors Market Export to Major Countries |
7.2 Zimbabwe Neuraminidase Inhibitors Market Imports from Major Countries |
8 Zimbabwe Neuraminidase Inhibitors Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in prescribing and administering neuraminidase inhibitors |
8.2 Patient adherence rate to neuraminidase inhibitors treatment regimens |
8.3 Number of clinical trials and research studies conducted on neuraminidase inhibitors |
8.4 Rate of influenza cases successfully treated with neuraminidase inhibitors |
8.5 Percentage of healthcare facilities equipped with adequate stock of neuraminidase inhibitors |
9 Zimbabwe Neuraminidase Inhibitors Market - Opportunity Assessment |
9.1 Zimbabwe Neuraminidase Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Zimbabwe Neuraminidase Inhibitors Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Zimbabwe Neuraminidase Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Zimbabwe Neuraminidase Inhibitors Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Zimbabwe Neuraminidase Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Zimbabwe Neuraminidase Inhibitors Market - Competitive Landscape |
10.1 Zimbabwe Neuraminidase Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 Zimbabwe Neuraminidase Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |